These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

90 related items for PubMed ID: 9588215

  • 1. Resistance to apoptosis induced by topoisomerase I inhibitors in multidrug-resistant HL60 leukemic cells.
    Palissot V, Belhoussine R, Carpentier Y, Sebille S, Morjani H, Manfait M, Dufer J.
    Biochem Biophys Res Commun; 1998 Apr 28; 245(3):918-22. PubMed ID: 9588215
    [Abstract] [Full Text] [Related]

  • 2. Factors contributing to the resistance to apoptosis induced by topoisomerase I inhibitors in vincristine resistant cells.
    Palissot V, Trussardi A, Gorisse MC, Dufer J.
    Adv Exp Med Biol; 1999 Apr 28; 457():355-63. PubMed ID: 10500811
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. The ability of selected pyridinium salts to increase the cytotoxic activity of vincristine but not doxorubicin towards sensitive and multidrug resistant promyelocytic leukaemia HL60 cells.
    Maruszewska A, Kostrzewa-Nowak D, Adamus J, Czupryńska K, Maryniak D, Gebicki J, Tarasiuk J.
    J Pharm Pharmacol; 2008 May 28; 60(5):647-53. PubMed ID: 18416942
    [Abstract] [Full Text] [Related]

  • 5. From molecular characteristics to cellular events in apoptosis-resistant HL-60 cells.
    Palissot V, Morjani H, Belloc F, Cotteret S, Dufer J, Berchem G.
    Int J Oncol; 2005 Mar 28; 26(3):825-34. PubMed ID: 15703842
    [Abstract] [Full Text] [Related]

  • 6. Two distinct modes of oncoprotein expression during apoptosis resistance in vincristine and daunorubicin multidrug-resistant HL60 cells.
    Belhoussine R, Morjani H, Gillet R, Palissot V, Manfait M.
    Adv Exp Med Biol; 1999 Mar 28; 457():365-81. PubMed ID: 10500812
    [Abstract] [Full Text] [Related]

  • 7. Topoisomerase inhibitor-induced apoptosis accompanied by down-regulation of Bcl-2 in human lung cancer cells.
    Oizumi S, Isobe H, Ogura S, Ishida T, Yamazaki K, Nishimura M, Kawakami Y, Dosaka-Akita H.
    Anticancer Res; 2002 Mar 28; 22(6C):4029-37. PubMed ID: 12553028
    [Abstract] [Full Text] [Related]

  • 8. Bioreductive activation of mitoxantrone by NADPH cytochrome P450 reductase does not change its apoptotic stimuli properties in regard to sensitive and multidrug resistant leukaemia HL60 cells.
    Kostrzewa-Nowak D, Tarasiuk J.
    Eur J Pharmacol; 2013 Dec 05; 721(1-3):141-50. PubMed ID: 24076328
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Inhibition of apoptotic proteins causes multidrug resistance in renal carcinoma cells.
    Scheltema JM, Romijn JC, van Steenbrugge GJ, Schröder FH, Mickisch GH.
    Anticancer Res; 2001 Dec 05; 21(5):3161-6. PubMed ID: 11848468
    [Abstract] [Full Text] [Related]

  • 12. Targeting biliverdin reductase overcomes multidrug resistance in leukemia HL60 cells.
    Kim SS, Seong S, Lim SH, Kim SY.
    Anticancer Res; 2013 Nov 05; 33(11):4913-9. PubMed ID: 24222129
    [Abstract] [Full Text] [Related]

  • 13. Detection of apoptosis induced by topoisomerase inhibitors and serum deprivation in syrian hamster embryo cells.
    Alexandre S, Rast C, Nguyen-Ba G, Vasseur P.
    Exp Cell Res; 2000 Feb 25; 255(1):30-9. PubMed ID: 10666331
    [Abstract] [Full Text] [Related]

  • 14. Complex response of breast epithelial cell lines to topoisomerase inhibitors.
    Davis PL, Shaiu WL, Scott GL, Iglehart JD, Hsieh TS, Marks JR.
    Anticancer Res; 1998 Feb 25; 18(4C):2919-32. PubMed ID: 9713486
    [Abstract] [Full Text] [Related]

  • 15. In vitro and in vivo reversal of multidrug resistance in a human leukemia-resistant cell line by mdr1 antisense oligodeoxynucleotides.
    Cucco C, Calabretta B.
    Cancer Res; 1996 Oct 01; 56(19):4332-7. PubMed ID: 8813118
    [Abstract] [Full Text] [Related]

  • 16. Altered topoisomerase IIalpha and multidrug resistance-associated protein levels during drug selection: adaptations to increasing drug pressure.
    Matsumoto Y, Takano H, Nagao S, Fojo T.
    Jpn J Cancer Res; 2001 Sep 01; 92(9):968-74. PubMed ID: 11572765
    [Abstract] [Full Text] [Related]

  • 17. Bcr-abl translocation can occur during the induction of multidrug resistance and confers apoptosis resistance on myeloid leukemic cell lines.
    Belloc F, Cotteret S, Labroille G, Schmit V, Jaloustre C, Dumain P, Durrieu F, Reiffers J, Boisseau MR, Bernard P, Lacombe F.
    Cell Death Differ; 1997 Dec 01; 4(8):806-14. PubMed ID: 16465293
    [Abstract] [Full Text] [Related]

  • 18. Correlation between expression of mdr-1 gene and oncogenes in human promyelocytic leukemic HL60 cell line and sublines.
    Zhou WD, Zhang HQ, Fang M, Xue SB.
    Zhongguo Yao Li Xue Bao; 1996 Sep 01; 17(5):471-3. PubMed ID: 9863178
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Down-regulation of apoptosis-related bcl-2 but not bcl-xL or bax proteins in multidrug-resistant MCF-7/Adr human breast cancer cells.
    Ogretmen B, Safa AR.
    Int J Cancer; 1996 Sep 04; 67(5):608-14. PubMed ID: 8782646
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.